Working… Menu
Trial record 1 of 1 for:    NCT04043104
Previous Study | Return to List | Next Study

A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04043104
Recruitment Status : Recruiting
First Posted : August 2, 2019
Last Update Posted : December 17, 2020
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : May 2022